What is the most likely cause of heavy and prolonged vaginal bleeding in a woman with a lesion in the uterine cavity as seen on pelvic ultrasound?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Most Likely Cause: Submucosal Leiomyoma

A discrete lesion within the uterine cavity on ultrasound in a woman presenting with heavy and prolonged menstrual bleeding is most consistent with a submucosal leiomyoma (Answer C), as submucosal fibroids directly impinge on the endometrial surface and disrupt normal hemostatic mechanisms, making them the primary cause of heavy menstrual bleeding when such a lesion is identified. 1

Diagnostic Reasoning

Why Submucosal Leiomyoma is Most Likely

  • Submucosal fibroids are specifically associated with heavy and prolonged bleeding patterns, which matches this patient's presentation perfectly 1
  • The ultrasound finding of a lesion in the uterine cavity is pathognomonic for either a submucosal leiomyoma or endometrial polyp 1
  • Excessive uterine bleeding is usually due to a submucous myoma or an intramural myoma encroaching into the uterine cavity 2
  • Hysteroscopic myomectomy is highly effective in controlling menorrhagia related to submucous myoma, confirming this as a well-established cause-effect relationship 2

Why NOT the Other Options

Endometrial Polyp (Option B):

  • While polyps can present as lesions in the uterine cavity, they typically cause intermenstrual bleeding more than the heavy, prolonged menstrual bleeding described in this case 1
  • Saline infusion sonohysterography has 97% accuracy in distinguishing leiomyomas from polyps when definitive differentiation is needed 1

Adenomyosis (Option A):

  • Adenomyosis does not present as a discrete lesion in the uterine cavity on ultrasound 1
  • Instead, it shows diffuse myometrial thickening, heterogeneous echotexture, and an ill-defined endomyometrial junction 1
  • The normal-sized uterus on examination makes extensive adenomyosis less likely, as adenomyosis typically causes uterine enlargement 1

Dysfunctional Uterine Bleeding (Option D):

  • DUB is a diagnosis of exclusion made only after structural pathology has been ruled out 1, 3
  • This patient has a documented structural lesion on ultrasound, which automatically excludes DUB as the diagnosis 1
  • When an organic cause of abnormal uterine bleeding cannot be found, only then is the diagnosis of dysfunctional uterine bleeding assumed 3

Next Steps in Management

Diagnostic Confirmation

  • If initial transvaginal ultrasound shows a focal endometrial abnormality, saline infusion sonohysterography provides 96-100% sensitivity for further characterization before surgical planning 1, 4
  • This can definitively distinguish between submucosal leiomyoma and endometrial polyp with 97% accuracy 1, 5

Treatment Approach

  • Medical therapy should be attempted first unless the structural pathology clearly requires surgery, with options including levonorgestrel-releasing IUD, combined oral contraceptives, or tranexamic acid 1, 4
  • The levonorgestrel-releasing intrauterine device is the first-choice medical treatment when postponing surgery or awaiting menopause, though the risk of expulsion in women with leiomyomas is approximately 20% 6
  • Hysteroscopic myomectomy is highly effective in controlling menorrhagia related to submucous myoma and should be considered if medical management fails 2

Clinical Pitfall to Avoid

Do not assume dysfunctional uterine bleeding when imaging has identified a structural lesion—this is a common error that delays appropriate treatment 1, 3

References

Guideline

Diagnosis and Management of Submucosal Leiomyoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of uterine fibroids for abnormal uterine bleeding: myomectomy and uterine artery embolization.

Best practice & research. Clinical obstetrics & gynaecology, 2007

Research

Differential diagnosis of abnormal uterine bleeding.

American journal of obstetrics and gynecology, 1996

Guideline

Uterine Leiomyoma Diagnosis and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnostic Approach to Abnormal Uterine Bleeding - Endometrial Causes

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the management for a 34-year-old female, 4 weeks pregnant, with spotting, light menstrual bleeding, cramping, and discomfort in the vaginal area?
What can be done to manage increased menstrual blood flow in a patient with irregular menses?
Is irregular vaginal bleeding in a 14-year-old female with no history of menarche (first menstrual period) and constipation indicative of delayed menarche?
What is the best course of management for a 34-year-old patient with a 6-month history of significant weight loss, nausea, vomiting, abdominal fullness, ovarian cysts, abnormal uterine bleeding, abnormal pap smear, bipolar depression, and a history of substance use and perforated ulcer?
What is the management plan for a 16-year-old female (YOF) with heavy vaginal bleeding, soaking a pad approximately every hour, nausea, and abdominal pain (7/10) for 3 days following an intrauterine device (IUD) insertion?
Is cystatin C (Cystatin C) a better estimate of estimated Glomerular Filtration Rate (eGFR) than creatinine?
What is the recommended dosage and usage of lignocaine (lidocaine) in medical procedures?
What are the symptoms of adrenal insufficiency?
What is the recommended management for a patient with Stage 2 Chronic Kidney Disease (CKD) and A2 albuminuria?
What is the estimated blood volume in milliliters per kilogram (ml/kg) or cubic centimeters per kilogram (cc/kg) for a 2-year-old girl?
What is the recommended treatment approach for severe major depression, including the use of Lexapro (escitalopram), Duloxetine, and Mirtazapine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.